“…We chose this setting to assess the sole effect of ZnO NPs in a wide concentration range from 1 µg/ml to 100 µg/mL independent of the transplant or implant material that is later chosen for the potential clinical application. ZnO NPs can be embedded in a variety of materials, among them gelatin [47], cellulose [22,61], alginate [20,[62][63][64], silica gels [65], chitosan [22,62,64,[66][67][68][69][70], different hydrogels [20][21][22]67,71,72], polycaprolactone [45,70,[73][74][75][76][77], polyvinyl alcohol [63,66], poly (vinlidene fluoride-trifluoroethylene) [45], polyurethane [62], calcium phosphate [78], polymethylmethacrylate [79], and polylactic acid [80], demonstrating the huge spectrum of biomaterials that can be modified using ZnO NPs. Since the CAM assay is an experiment that is not carried out with genetically identical organisms and during the highly dynamic embryonic development, it is a system that is subject to large interindividual variations.…”